Velpatasvir
| CAS No. | 1377049-84-7 |
|---|---|
| MDL No. | MFCD28411371 |
| MF | C49H54N8O8 |
| MW | 883.00 |
| InChI Key | FHCUMDQMBHQXKK-CDIODLITSA-N |
| CAS No. | 1377049-84-7 |
|---|---|
| MDL No. | MFCD28411371 |
| MF | C49H54N8O8 |
| MW | 883.00 |
| InChI Key | FHCUMDQMBHQXKK-CDIODLITSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Velpatasvir is a complex organic heteropentacyclic compound and hepatitis C virus nonstructural protein 5A inhibitor used in combination with sofosbuvir (brand name: Epclusa) to treat chronic hepatitis C of all six major genotypes. It functions as an antiviral drug and is classified as an N-acylpyrrolidine, a L-valine derivative, a carbamate ester, an imidazole, a ring assembly, and an ether.
| CAS No. | 1377049-84-7 |
|---|---|
| Product Name | Velpatasvir |